Four leading cancer research organizations in the United States and Canada announce the opening of patient enrollment to myeloMATCH, a unique portfolio of clinical trials to test precision medicine ...
Society of Hematologic Oncology opens registration for case-based MDS/AML program ahead of SOHO 2026
This in-person session titled, "Practical Strategies for Optimizing Outcomes in MDS and AML," will be held on Sept. 8, 2026, from 3 to 5 pm CST, and will feature case-based discussions. The session ...
(Logo: http://www.newscom.com/cgi-bin/prnh/20091117/DA12265LOGO) The program was sponsored in part by a $2.7 million federal educational grant received through the ...
Through its Centers of Excellence program, the MDS Foundation helps patients get appointments with leading experts from around the world. For patients with cancer there is no time to waste. The MDS ...
WHITE PLAINS, N.Y., Sept. 20, 2012 /PRNewswire/ -- Thanks to support funding from The Leukemia & Lymphoma Society (LLS), Onconova Therapeutics, Inc. has been advancing rigosertib, the lead compound ...
NEW YORK, Oct. 30, 2018 /PRNewswire/ -- Actinium Pharmaceuticals, Inc. (NYSE American: ATNM) announced today that the next stage of development for its CD33 ARC (Antibody Radiation Conjugate) ...
Results from a retrospective study compared and explored biomarkers associated with outcomes in myelodysplastic syndrome (MDS) with plasma cell neoplasms. MDS is a group of heterogeneous clonal ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results